Previous Page TOC Index Next Page

7.8.2 CRM - message when patient begins a phase of a clinical trial

MSH|^~\&|PDMS|MDACC|PHARM|MDACC|||CRM^C05 <cr>
CMO|1|ID91-025^^MDACC||Double Blind, Multicenter Study of 13-Cis 

.....Retinoic Acid to Prevent Secondary Primary Tumors^MDACC|
.....863^McDougall^Lester^^^^MD^MDACC|19940701|312|19941227 <cr>
CM1|1|2^Treatment^PDMS|Daily Drug/Placebo Treatment|3^YEARS <cr>
PID|1||352352||West^Mary^L.||19230213 <cr>
CSR||ID91-025^^MDACC||MDACC|301||19941005|||||19941201|2^blind^PDMS|

12^Smoker,Stage II,<60^PDMS <cr>
CSP||2^Treatment^PDMS|19941201 <cr>

Previous Page TOC Index Next Page